Recopharma AB
Goteborg, SE· latest recorded location
Recopharma AB is named on 3 US grants and 10 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 3
- Published applications
- 10
- Inventors
- 7
- Granted in 2026 so far
- 0
- Most recent grant
- 11 Oct 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 3 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 3 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
By publication year.
Technology areas
Share of 13 documents
Recent patents
- Mucin fusion polypeptide vaccines, compositions and methods of use thereof11 Oct 2011US 8,034,351 B2
- Compositions and methods for inhibiting H. pylori adhesion and infection9 Feb 2010US 7,658,919 B2
- Fusion proteins and methods of producing same29 Dec 2009US 7,638,323 B2
- Compositions and Methods for Inhibiting Viral Adhesion11 Sep 2014US 2014/0256019 A1
- Tear Substitutes28 Jun 2012US 2012/0165272 A1
- Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof9 Feb 2012US 2012/0034220 A1
- Compositions And Methods For Inhibiting Viral Adhesion26 Jan 2012US 2012/0020969 A1
- Antigenic fusion protein carrying gal alpha1,3gal epitopes19 Nov 2009US 2009/0286963 A1
Most cited
By later US patents